Although βAR agonists and antagonists have therapeutic effectiveness for heart failure treatment, there are still patients who do not respond effectively; thus, heart failure is the most common cause of mortality worldwide (Capote et al., 2015). The gene discussed is ADRB2; the disease is heart failure.